期刊文献+

miRNA-143在同型半胱氨酸致血管平滑肌细胞增殖中作用的研究 被引量:4

Effect of miRNA-143 on homocysteine induced vascular smooth muscle cell proliferation
下载PDF
导出
摘要 目的探讨miRNA-143在同型半胱氨酸(homocysteine,Hcy)致血管平滑肌细胞增殖中的作用。方法原代培养血管平滑肌细胞(vascular smooth muscle cells,VSMCs),用不同浓度的Hcy和叶酸干预,MTT法检测VSMCs增殖情况,qRT-PCR法检测miR-143的表达,巢式降落式特异性甲基化PCR法分析miR-143启动子区的甲基化状态,分别用miR-143的前体和抑制物转染细胞检测细胞增殖。结果不同浓度的Hcy均可以引起VSMCs增殖活性增强,miR-143的mRNA表达降低,miR-143启动子区甲基化程度升高,以100μmol·L^(-1)Hcy最为明显(P<0.01),miR-143前体作用VSMCs后,细胞的增殖活性减弱(P<0.01),细胞转染miR-143的抑制物后细胞增殖活性明显增强(P<0.01)。结论 miR-143可以抑制VSMCs增殖,其机制可能与miR-143启动子区高甲基化有关。 Aim To explore the effect of miRNA-143 (miR-143 ) on homocysteine ( Hey ) induced - vascular smooth muscle cells ( VSMCs ) proliferation and themechanism. Methods VSMCs were cultured and incubatedwith Hey by using primary cultured method.T h e n, cells were treated with different concentrationsof Hey and folate. VSMCs proliferation was determinedwith M T T assay,miR -143 was measured by qRT-PCR ,and methylation of miR -143 was determined with methylatedP CR . Results After cells were treated with differentconcentrations of Hey , the proliferation ofVSMCs was significantly increased, mRNA expressionof miR -143 was decreased and methylation of miR -143was increased. The proliferation of VSMCs was significantlydecreased when transfected VSMCs with miR -143 precursor,and cell proliferation was increased byusing miR -143 inhibitor transfection. Conclusion H y -pomethylation of miR -143 may inhibit VSMCs proliferation.
出处 《中国药理学通报》 CAS CSCD 北大核心 2016年第8期1097-1101,共5页 Chinese Pharmacological Bulletin
基金 宁夏自然科学基金资助项目(No NZ15209) 国家自然科学基金资助项目(No 81360027 81360052 81360053)
关键词 mRNA-143 同型半胱氨酸 血管平滑肌细胞 增殖 甲基化 表达 miRNA -143 homocysteine vascularsmooth muscle cells proliferation methylation expression
  • 相关文献

参考文献5

二级参考文献39

  • 1陈芳,殷勤伟.调控基因表达的miRNA[J].科学通报,2005,50(13):1289-1299. 被引量:21
  • 2谷伟军,陆菊明,杨国庆,郭清华,窦京涛,母义明,潘长玉.甲钴胺及叶酸治疗对2型糖尿病同型半胱氨酸硫内酯解酶活性和血浆同型半胱氨酸水平的影响[J].中华医学杂志,2007,87(4):256-258. 被引量:22
  • 3Insull W Jr. The pathology of atherosclerosis: plaque devel- opment and plaque responses to medical treatment. Am J Med 2009; 122:s3 -s14. 被引量:1
  • 4Kanjuh V, Ostojid M, Lalid N, et al. Low and high density lipoprotein-cholesterol and coronary atherothrombosis. Med Preg12009; 62:7 14. 被引量:1
  • 5Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ). JAMA 2001; 285: 2480-2497. 被引量:1
  • 6Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction oflifetime risk for cardiovascular disease by risk Pactor burden at 50 years of age. Circulation 2006; 113:791 798. 被引量:1
  • 7McCully KS. Vascular pathology of homocysteinemia: im- plications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111-128. 被引量:1
  • 8McCully KS. Homocysteine and vascular disease. Nat Med 1996; 2: 386-389. 被引量:1
  • 9Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19: 217 246. 被引量:1
  • 10Hofmann MA, Lalla E, Lu Y, et ol. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclero- sis in a murine model. J Clin Invest 2001 ; 107:675 683. 被引量:1

共引文献69

同被引文献26

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部